WebNov 11, 2024 · (See "Low-density lipoprotein cholesterol lowering with drugs other than statins and PCSK9 inhibitors", section on 'Ezetimibe'.) Supporting data for ezetimibe for treatment of LDL-C in older adults is limited. One study reported a potential benefit of ezetimibe, but there were too many limitations to guide therapy; these included an open … WebCholesterol. This practical quick-reference tool contains screening, primary and secondary prevention, diagnosis, drug therapy, and dosing information and recommendations for the hyperlipidemias; treatment algorithms; patient monitoring; racial, ethnic and age differences; comorbidities and statin side effects.

Cholesterol: Top foods to improve your numbers - Mayo Clinic

WebApr 15, 2024 · Strong evidence supports moderate-dose statins as the best therapy in primary prevention for patients at elevated risk, with relative risk reductions in cardiovascular events and mortality of 20% ... mantle national geographic society

Cholesterol - Clinical Practice Guideline AAFP

WebNov 10, 2024 · In very high-risk ASCVD, use an LDL-C threshold of 70 mg/dl (1.8 mmol/L) to consider addition of nonstatins to statins. In very high-risk ASCVD patients, it is reasonable to add ezetimibe to maximally tolerated statin therapy when the LDL-C level remains ≥70 mg/dl (≥1.8 mmol/L). In patients at very high risk whose LDL-C level remains ≥70 ... WebMar 20, 2024 · Check your cholesterol regularly. You may need to have your cholesterol levels tested at least once every 4 to 6 years if you do not have heart disease. Some people need to get their cholesterol checked more often or less often. Talk with your health care team about the timeline that is best for you. Learn about getting your cholesterol checked. WebNov 10, 2024 · The writing group created a simplified algorithm of 4 groups who were most likely to benefit from moderate- or high-intensity statin therapy ( Table ). This approach … kowhai tree flowering